{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Added in vitro to rat cortical membrane preparation , abecarnil increased [ 3H ] GABA binding , enhanced muscimol - stimulated 36Cl - uptake and reduced the binding of t - [ 35S ] butylbicyclophosphorothionate ( [ 35S ] TBPS ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None mentioned |\n\nThe paragraph does not mention any diseases. It discusses the effects of a compound called abecarnil on various physiological processes in rat cortical membrane preparations, including GABA binding, muscimol-stimulated 36Cl-uptake, and the binding of t-[35S] butylbicyclophosphorothionate ( [35S] TBPS ). Therefore, there are no disease entities in this paragraph."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| None |\n\nThe paragraph does not mention any diseases. The entities mentioned are:\n\n* abecarnil: a compound used in the experiments\n* GABA: a neurotransmitter\n* muscimol: a drug that stimulates GABA receptors\n* 36Cl-uptake: a process involving the uptake of chlorine-36 by cells\n* t-[35S] butylbicyclophosphorothionate ( [35S] TBPS ): a compound used as a ligand in the experiments\n\nNone of these entities clearly refer to a disease, so the table above contains no entries."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Added in vitro to rat cortical membrane preparation , abecarnil increased [ 3H ] GABA binding , enhanced muscimol - stimulated 36Cl - uptake and reduced the binding of t - [ 35S ] butylbicyclophosphorothionate ( [ 35S ] TBPS ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| [3H] GABA |\n| muscimol |\n| [36Cl] |\n| t-[35S] butylbicyclophosphorothionate ( [35S] TBPS ) |\n\nNote:\n\n* [3H] GABA refers to GABA labeled with tritium (3H)\n* [36Cl] refers to chlorine-36 (36Cl)\n* t-[35S] butylbicyclophosphorothionate ( [35S] TBPS ) refers to a compound labeled with sulfur-35 (35S)"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| [3H] GABA |\n| muscimol |\n| [35S] TBPS |\n\nNote:\n\n* [3H] GABA refers to GABA labeled with tritium (3H)\n* muscimol is a chemical compound\n* [35S] TBPS refers to a compound labeled with sulfur-35 (35S)\n\nThe following entities were removed from the original list as they do not clearly refer to chemicals:\n\n* rat cortical membrane preparation (not a chemical)\n* in vitro (not a chemical)\n* t- (not a chemical)\n* butylbicyclophosphorothionate (not a chemical)\n* Cl (not a chemical)"}
  ]
}